Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Elucidata builds Polly, a platform that cleans, harmonises and annotates biomedical data so that machine learning models can use it. Founded in 2016 by IIT graduates with offices in Cambridge and Delhi, it addresses the fact that most life science data is not analysis-ready. Its customers include large pharmaceutical companies and biotech startups.

News

News Drug Target Review 2 months ago
Why single-cell foundation models have underdelivered and what drug discovery needs instead
Foundation models have delivered breakthroughs in protein biology, but single-cell models have struggled to match them. What is holding them back?
Read more
Report
News bitsinbio.substack.com 3 years ago
FAIR Data Infrastructure in Life Sciences R&D
Navigating the complexities and challenges in preclinical drug discovery (Part 1 of 3)
Read more
Report
News Deep Pharma 3 years ago
AI for DD Landscape: Focus on Asia Deep Pharma Intelligence
This "World's AI for Drug Development Landscape: Focus on Asia" report represents the eleventh issue of market analytics focused on the Artificial Intelligence (AI) application in the pharmaceutical research industry and especially in Asia region.
Read more
Report
News Andreessen Horowitz 3 years ago
Doing More with Moore: Biotech's Tech Moment
The biotech industry's appetite for science-native SaaS tools is accelerating and will modernize how medicines are discovered, developed, and distributed.
Read more
Report
News Extreme Tech Challenge 3 years ago
Extreme Tech Startup Spotlight: Elucidata
This week in our Startup Spotlight blog series is our 2020 XTC Healthcare Finalist - Elucidata
Read more
Report
News ACL Anthology 4 years ago
Reducing Inference Time of Biomedical NER Tasks using Multi-Task Learning
Mukund Chaudhry Chaudhry, Arman Kazmi, Shashank Jatav, Akhilesh Verma, Vishal Samal, Kristopher Paul, Ashutosh Modi. Proceedings of the 19th International Conference on Natural Language Processing (ICON). 2022.
Read more
Report
News Moneycontrol 4 years ago
Elucidata raises $16 million in series A led by Eight Roads Ventures- Moneycontrol.com
The funds raised will be used by Elucidata's data-centric Machine Learning Operations (ML-Ops) platform, Polly to deepen product capabilities in translational drug research and allied markets, scale go-to-market initiatives and accelerate global expansion
Read more
Report
News The SaaS News 4 years ago
Elucidata Raises $16 Million in Series A
Elucidata, a Cambridge, MA-based TechBio company that powers life science research and development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly, announced that it raised $16 million in Series A funding.
Read more
Report
News Inc42 Media 4 years ago
Healthtech Startup Elucidata Bags $16 Mn To Scale SaaS Platform Polly
Delhi-based healthtech startup Elucidata has raised $16 Mn as part of its Series A funding round led by investment firm Eight Roads Ventures.
Read more
Report
Show more news

People

Abhishek Jha
Executive Officer, Director
Swetabh Pathak
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge United States
HQ

Financials

Total raised
$18.6M
Latest round
Series A
Funding rounds
3
Funding rounds
Round Announced Amount
Series A 2022 $16M Details
Debt Financing 2020 $880k Details
Venture - Series Unknown 2018 $1.7M Details